Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119912) titled 'Exploring the application of remimazolam besylate in general anesthesia ... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07459530) titled '[Trial of device that is not approved or cleared by the U.S. FDA]' on March 5... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07459582) titled 'Accuracy of Home Lactate Meter and Accu-chek Glucometer in Patients With Glyc... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07459673) titled 'HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapi... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07459725) titled 'Comparison of EEG-Timed vs. Repetitive Robot Therapy for Chronic Stroke' on M... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07459543) titled 'A Study To Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixe... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07459595) titled 'Metformin Versus Myo-inositol in the Management of Polycystic Ovarian Disease... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07459634) titled 'A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of ... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07459686) titled 'An Observational Study to Learn About Velsipity After Long Term Use in Patien... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07459738) titled 'A Phase II Study to Evaluate the Efficacy and Safety of HLX43 in Patients Wit... Read More